(Q73708688)
Statements
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia (English)
Jaroslaw P Maciejewski
Elaine M Sloand
Olga Nunez
Carol Boss
scientific article published on 24 July 2003